Boyd Peter E. 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
Aquestive (AQST) CPO Peter Boyd Sells Shares, Receives Awards
What Happened Peter E. Boyd, Chief People Officer of Aquestive Therapeutics, sold 29,814 shares in an open-market transaction on 2026-03-10 for a weighted average price of $4.17, totaling about $124,414. On 2026-03-09 he received two awards: 80,000 shares of restricted stock (reported at $0) and a derivative award covering 42,500 shares reported at $4.29 each (total reported value $182,325).
Key Details
- Dates and prices:
- 2026-03-09: Award of 80,000 restricted shares @ $0 reported.
- 2026-03-09: Derivative award of 42,500 shares @ $4.29 (reported value $182,325).
- 2026-03-10: Sale of 29,814 shares @ weighted avg $4.17, proceeds ~$124,414 (sale executed in multiple trades at $4.17–$4.33). (F3)
- Shares owned after the transactions: not specified in the filing.
- Notable footnotes:
- F1: The 80,000 restricted shares vest in three annual installments (25%/25%/50%).
- F4: The derivative/options vesting schedule is also 25%/25%/50%.
- F2: The 29,814-share sale was a mandatory "sell-to-cover" to satisfy tax withholding on vesting and was not a discretionary trade by the reporting person.
- Filing timeliness: Form filed 2026-03-11 for transactions on 2026-03-09/03-10 — not indicated as late.
Context These transactions reflect routine equity compensation activity: receipt of restricted stock and derivative awards (subject to multi-year vesting) and a mandated sell-to-cover to cover tax withholding. The sale appears to be procedural rather than a voluntary investment decision; awards vest over time and are not an immediate cash purchase/sale signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-09+80,000→ 368,323 total - Sale
Common Stock
[F2][F3]2026-03-10$4.17/sh−29,814$124,414→ 338,509 total - Award
Non-Qualified Stock Option (right to buy)
[F4]2026-03-09$4.29/sh+42,500$182,325→ 42,500 totalExercise: $4.29Exp: 2036-03-09→ Common Stock (42,500 underlying)
Footnotes (4)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]This transaction was executed in multiple trades at prices ranging from $4.17 to $4.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.